A Fe-incorporated bioreactor platform exhibiting antimalarial activity and enhanced response to artemisinin
Antimicrobial Agents and Chemotherapy · 2026
DOI: 10.1128/aac.01390-25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2026. Verfasst von Yinyue Li und 11 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medical Sciences, Faculty of Medicine, Yangzhou University, Yangzhou, China. Hauptthemen laut MEDLINE: Artemisinins, Antimalarials, Plasmodium falciparum, Iron. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
While malaria parasites rely on labile Fe 2+ pools for survival, excess Fe 2+ acts as a Fenton reagent, inducing cytotoxicity via reactive oxygen species and membrane disruption, highlighting iron homeostasis as a key therapeutic vulnerability. To test the feasibility of iron ions in inhibiting Plasmodium parasites, we developed Fe 2+ -loaded polydopamine nanoparticles (PDA@Fe/P) that exploit the parasite’s iron-dependent vulnerabilities through dual mechanisms: (i) sustained Fe 2+ release triggers Fenton reactions, generating cytotoxic hydroxyl radicals that overwhelm antioxidant defenses, and (ii) restoration of artemisinin (ART) activation in resistant parasites by supplementing the diminished Fe 2+ pool. In vitro testing against five P. falciparum strains (including chloroquine- and ART-resistant variants) demonstrated potent, antimalarial activity, with efficacy 20-fold higher than free FeCl 2 due to enhanced solubility and controlled release. While in vivo studies in P. berghei -infected mice showed transient parasite suppression without toxicity, the relatively high IC 50 precludes standalone use. Crucially, PDA@Fe/P enhanced the activity of ART against P. falciparum strain with partial ART resistance conferred by Kelch13 mutation, by counteracting mutation-induced impairments in hemoglobin endocytosis and heme bioavailability—key determinants of ART activation. Analysis of lipid peroxidation levels revealed that Fe 2+ delivered via PDA@Fe/P amplifies oxidative stress responses in resistant parasites, indicating its ability to enhance the sensitivity of ART-resistant strains to ART. Our findings establish iron-based delivery strategies as a promising approach to potentiate existing antimalarials and combat resistance through the targeted disruption of redox homeostasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Basic Medical Sciences, Faculty of Medicine, Yangzhou University, Yangzhou, China.
- Autobio Diagnostics Co., Ltd., Zhengzhou, China.
- School of Traditional Chinese Medicine, Faculty of Medicine, Yangzhou University, Yangzhou, Jiangsu, China.
- Key Laboratory of the Jiangsu Higher Education Institutions for Integrated Traditional Chinese and Western Medicine in Senile Diseases Control (Yangzhou University), Yangzhou, Jiangsu, China.
- Department of Tropical Medicine, School of Medicine, Kangwon National University, Chuncheon, Korea.
- The Key Laboratory of the Jiangsu Higher Education Institutions for Nucleic Acid & Cell Fate Regulation, Yangzhou University, Yangzhou, China.
ORCID-Profile: Feng Lu
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Li, Y., Li, S., Li, H., Yang, Y., Xu, J., Deng, Y., He, X., Tian, F., Han, J. H., Han, E. T., Xi, J., & Lu, F. (2026). A Fe-incorporated bioreactor platform exhibiting antimalarial activity and enhanced response to artemisinin. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.01390-25
Vancouver
Li Y, Li S, Li H, Yang Y, Xu J, Deng Y, et al. A Fe-incorporated bioreactor platform exhibiting antimalarial activity and enhanced response to artemisinin. Antimicrobial Agents and Chemotherapy. 2026. doi:10.1128/aac.01390-25
BibTeX
@article{Li2026,
author = {Li, Yinyue and Li, Shuang and Li, Huajun and Yang, Yun and Xu, Jiahui and Deng, Ying and He, Xinlong and Tian, Fang and Han, Jin-Hee and Han, Eun-Taek and Xi, Juqun and Lu, Feng},
title = {A Fe-incorporated bioreactor platform exhibiting antimalarial activity and enhanced response to artemisinin},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2026},
doi = {10.1128/aac.01390-25}
}
EUVIMED